Abstract: The present invention relates to anti-human metapneumovirus (hMPV) antibodies, as well as use of such antibodies in the treatment of viral infections. The invention also includes antigenic hMPV proteins and immunogenic compositions comprising such antigenic hMPV proteins, and the use of such antigenic hMPV proteins and related compositions for preventing or treating viral infection in a subject.

Abstract: The present invention pertains to the technical field of aeromagnetic survey, and specifically pertains to a storage device for a data analyzer for aerospace magnetic field measurement, which comprises a storage box body, a moving structure for facilitating movement is connected to the storage box body, a shielding structure for shielding sunlight is connected to the storage box body, an accommodating structure for accommodating an article is connected to the storage box body, a support structure for supporting is connected to the accommodating structure, and a placing structure for placing is connected to the storage box body.

Abstract: In one novel aspect, OFDM RS symbols are configured with zero-power RS occupying either all even subcarrier or all odd subcarriers and the non-zero-power RS occupy all or part of remaining subcarriers. In one embodiment, even component RS symbols and odd component RS symbols are alternatively inserted in data frames with frequency offsets. In one embodiment, the receiver performs a wireless sensing by sampling a final-half duration with phase preprocessing. In one novel aspect, the target distance and velocity are uniquely determined via estimating clustering-range rate during successive CPIs. In one embodiment, the UE performing successive sensing for multiple clusters based on the diamond-shaped RS configuration during N successive CPIs, and a range rate for each cluster, selects a cluster with velocity that matches the calculated range rate, and determines a target distance and velocity based on the selected cluster.

Abstract: The present invention pertains to the technical field of aeromagnetic survey, and specifically pertains to a storage device for a data analyzer for acrospace magnetic field measurement, which comprises a storage box body, a moving structure for facilitating movement is connected to the storage box body, a shielding structure for shielding sunlight is connected to the storage box body, an accommodating structure for accommodating an article is connected to the storage box body, a support structure for supporting is connected to the accommodating structure, and a placing structure for placing is connected to the storage box body.

Abstract: Method for predicting a stability of a steel cylinder including: in response to the steel cylinder tilting toward a seaward side at an arbitrary rotation point, obtaining a safety factor for the steel cylinder tilting toward the seaward side by determining an anti-tilt moment and a tilt moment when the steel cylinder is tilted to the seaward side; under a same rotation point, in response to determining that the steel cylinder is rotated toward a land side, determining the safety factor for the steel cylinder tilting toward the land side; taking a smaller safety factor as the safety factor under the rotation point; re-selecting a new rotation point, determining a safety factor corresponding to the new rotation point, and taking a safety factor with a smallest value among all rotation points as a final safety factor; and generating, based on the final safety factor, an anti-tilt instruction.

Abstract: A random access method, device, and equipment are disclosed. The method includes: receiving, by a network node, a random access request, wherein the random access request comprises a preamble and a first data block; and sending, by the network node, a random access response.

Abstract: The present invention relates to monoclonal antibodies which have high anti-RSV neutralizing titers. The invention further provides for isolated nucleic acids encoding the antibodies of the invention and host cells transformed therewith. The invention yet further provides for diagnostic, prophylactic and therapeutic methods employing the antibodies and nucleic acids of the invention, particularly as a passive immunotherapy agent in infants and the elderly.

Abstract: The invention provides for compositions comprising phosphorous containing tricyclic compounds, including phthalazin-1(2H)-one derivatives. The compounds are potent inhibitors of the enzyme poly(ADP-ribose)polymerase (PARP), particularly PARP-1 and potentially PARP-2. The also show good cellular activity in inhibiting poly(ADP-ribose) oligomer formation. The compounds may be useful as mono-therapy or in combination with other therapeutic agents in the treatment conditions where PARP is implicated, such as cancer, inflammatory diseases and ischemic conditions. Thus, also provided are methods for the treatment of a condition where PARP is implicated comprising administering to an effective amount of a compound of the invention to an individual in need thereof.

Abstract: The invention provides alkyne substituted quinazoline compounds, such as compounds of the formula (I), which are irreversible ErbB kinase inhibitors. The compounds are useful in the treatment of diseases and disorders where ErbB kinase activity is implicated such as a hyperproliferative disorder (e.g., cancer).

Abstract: A photography lamp includes a housing assembly, a heat dissipation assembly, and a light source assembly. The housing assembly includes a lamp barrel and a rear cover, a main air inlet is disposed on the rear cover, and an air outlet grille is disposed on a side wall of the lamp barrel close to the light outlet end. The heat dissipation assembly includes a fan, the air outlet side of the fan is spaced from the light source assembly, a spacing is arranged between the air outlet side of the fan and the light source assembly, and the spacing is always facing the air outlet grille in the direction of the central axis of the lamp barrel. The photography lamp can improve heat dissipation efficiency of photographic lighting fixtures.

Abstract: The invention provides for compositions comprising phosphorous containing tricyclic compounds, including phthalazin-1(2H)-one derivatives. The compounds are potent inhibitors of the enzyme poly(ADP-ribose)polymerase (PARP), particularly PARP-1 and potentially PARP-2. The also show good cellular activity in inhibiting poly(ADP-ribose) oligomer formation. The compounds may be useful as mono-therapy or in combination with other therapeutic agents in the treatment conditions where PARP is implicated, such as cancer, inflammatory diseases and ischemic conditions. Thus, also provided are methods for the treatment of a condition where PARP is implicated comprising administering to an effective amount of a compound of the invention to an individual in need thereof.

Abstract: A photography lamp includes a housing assembly, a heat dissipation assembly, and a light source assembly. The housing assembly includes a lamp barrel and a rear cover, a main air inlet is disposed on the rear cover, and an air outlet grille is disposed on a side wall of the lamp barrel close to the light outlet end. The heat dissipation assembly includes a fan, the air outlet side of the fan is spaced from the light source assembly, a spacing is arranged between the air outlet side of the fan and the light source assembly, and the spacing is always facing the air outlet grille in the direction of the central axis of the lamp barrel. The photography lamp can improve heat dissipation efficiency of photographic lighting fixtures.

Abstract: A functional polymer of styrene derivative a copolymer of a monomer A having the structure represented by the formula (I) and a comonomer. The functional polymer of styrene derivative of the present invention can be easily further chemically modified. Meanwhile, basic properties of the functional polymer, such as glass transition temperature, viscoelasticity and the like, can be easily adjusted by adjusting the amount of the styrene derivative added.

Abstract: The invention provides alkyne substituted quinazoline compounds, such as compounds of the formula (I), which are irreversible ErbB kinase inhibitors. The compounds are useful in the treatment of diseases and disorders where ErbB kinase activity is implicated such as a hyperproliferative disorder (e.g., cancer).

Abstract: The invention provides lor compositions comprising phosphorous containing tricyclic compounds, including phthalazin-1(2H)-one derivatives. The compounds arc potent inhibitors of the enzyme poly(ADP-ribose)polymerase (PARP), particularly PARP-1 and potentially PARP-2. The also show good cellular activity in inhibiting poly(ADP-ribose) oligomer formation. The compounds may be useful as mono-therapy or in combination with other therapeutic agents in the treatment conditions where PARP is implicated, such as cancer, inflammatory diseases and ischemic conditions. Thus, also provided are methods for the treatment of a condition where PARP is implicated comprising administering to an effective amount of a compound of the invention to an individual in need thereof.

Abstract: The invention provides alkyne substituted quinazoline compounds, such as compounds of the formula (I), which are irreversible ErbB kinase inhibitors. The compounds are useful in the treatment of diseases and disorders where ErbB kinase activity is implicated such as a hyperproliferative disorder (e.g., cancer).

Abstract: A functional polymer of styrene derivative a copolymer of a monomer A having the structure represented by the formula (I) and a comonomer. The functional polymer of styrene derivative of the present invention can be easily further chemically modified. Meanwhile, basic properties of the functional polymer, such as glass transition temperature, viscoelasticity and the like, can be easily adjusted by adjusting the amount of the styrene derivative added.

Abstract: A styrenic monomer-diolefin copolymer comprises polystyrenic monomer micro-blocks and polydiolefin micro-blocks, in which the content of styrenic monomer units is 10-80 wt %, the ratio of diolefin units of 1,2-structure is less than 30% in the total diolefin units, and the number-average molecular weight (Mn) of the copolymer is 25,000-500,000. The preparation methods and uses in foam products thereof are also disclosed.

Abstract: The invention provides for compositions comprising phosphorous containing tricyclic compounds, including phthalazin-1(2H)-one derivatives. The compounds are potent inhibitors of the enzyme poly(ADP-ribose)polymerase (PARP), particularly PARP-1 and potentially PARP-2. The also show good cellular activity in inhibiting poly(ADP-ribose) oligomer formation. The compounds may be useful as mono-therapy or in combination with other therapeutic agents in the treatment conditions where PARP is implicated, such as cancer, inflammatory diseases and ischemic conditions. Thus, also provided are methods for the treatment of a condition where PARP is implicated comprising administering to an effective amount of a compound of the invention to an individual in need thereof.

Abstract: The invention provides alkyne substituted quinazoline compounds, such as compounds of the formula (I), which are irreversible ErbB kinase inhibitors. The compounds are useful in the treatment of diseases and disorders where ErbB kinase activity is implicated such as a hyperproliferative disorder (e.g., cancer).